A Canadian scientist's significant discovery of the GLP-1 hormone has earned him the Breakthrough Prize in Life Sciences, recognizing a finding that is pivotal in the development of diabetes and obesity medications including Ozempic, Wegovy, and Mounjaro. The recognition highlights his contribution to advancing medical treatments that have improved the lives of millions.
Canadian researcher Dr. Daniel Drucker wins a 2025 Breakthrough Prize in Life Sciences, sharing $3 million for discovering the GLP-1 hormone used in life-changing diabetes and obesity drugs like Ozempic, Wegovy, and Mounjaro worldwide.
Physician at Toronto’s Lunenfeld-Tanenbaum Research Institute was one of five researchers jointly awarded US$3-million in world’s largest science prize
A Canadian scientist has won a 2025 Breakthrough Prize in Life Sciences for discovering a hormone used in diabetes and obesity medications that has changed the lives of millions.
TORONTO - A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes and obesity medications — including Ozempic, Wegovy and Mounjaro — that have changed the lives of millions of…
5 stories from sources in 20.1 hour(s) #healthcare #ontario #albert
Ontario Suspends Students Amid Measles Outbreak and Health Warnings
Canada Braces for U.S. Tariffs Amid Escalating Trade War
Trump launches sweeping reciprocal tariffs as Canada braces fallout
Officials face backlash after mistaken deportation of Maryland man
Canadian Leaders Rally Against Trump's Tariff Crisis Impacting Public Services
Toronto confronts wintry storm with sudden flooding alerts
Toronto home sales plunge amid mounting trade concerns
Ontario Updates Measles Outbreak Count Amid Rising Hospitalizations
Calgary charges man over deadly Stoney Trail hit-and-run crash
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.